Connection

Anna Ridolfo to Pneumonia, Viral

Back to Details
This is a "connection" page, showing publications Anna Ridolfo has written about Pneumonia, Viral.
Anna Ridolfo
Connection Strength
0.070
Pneumonia, Viral
  1. Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia. Infez Med. 2020 Jun 01; 28(suppl 1):29-36.
    View in: PubMed
    Score: 0.028
  2. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020 07 28; 71(15):889-890.
    View in: PubMed
    Score: 0.007
  3. SARS-COV-2 infection: Across the border into the family. Travel Med Infect Dis. 2020 Jul - Aug; 36:101784.
    View in: PubMed
    Score: 0.007
  4. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study. Pharmacol Res. 2020 08; 158:104931.
    View in: PubMed
    Score: 0.007
  5. Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy. Eur J Intern Med. 2020 06; 76:36-42.
    View in: PubMed
    Score: 0.007
  6. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status. Pharmacol Res. 2020 08; 158:104899.
    View in: PubMed
    Score: 0.007
  7. Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? Autoimmun Rev. 2020 07; 19(7):102564.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.